The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).

导出原文传递

翻译打印收藏纠错

作者： Mellgren K ^[1] ; Skogby M ^[2] ; Friberg LG ^[3] ; Tengborn L ; Wadenvik H

作者单位： hys.keio.ac.jp ^[1] ediat.gu.se ^[2] Department of Paediatrics, Sahlgrenska University Hospital, University of Goteborg, Sweden. vobmel ^[3]

关键词 Anticoagulants Blood Coagulation Extracorporeal Circulation Guanidines 抗凝药血液凝固体外循环胍类血小板活化丝氨酸蛋白酶抑制剂

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Thrombosis and Haemostasis

1998年79卷2期

342-347页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).

Thrombosis and Haemostasis

相似文献

Thrombosis and Haemostasis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).

Thrombosis and Haemostasis

相似文献

Thrombosis and Haemostasis

相关期刊

检索历史清除